Fondazione IRCCS, Istituto Nazionale dei Tumori, SC Oncologia Medica 2

Milan 20133

0 studies enrolling now · 2 studies all time

What they study most

Kidney Neoplasms

Studies at this site

• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer — Completed